BROOKLYN PARK, Minn.--(BUSINESS WIRE)--Five studies exploring different aspects of CHF Solutions’ unique form of ultrafiltration therapy to treat fluid overload in heart failure patients (Aquapheresis™) were presented in poster sessions at the Heart Failure Society of America (HFSA) 2006 Annual Scientific Meeting in Seattle. The new studies expand on, and are consistent with, findings from previous studies, most recently, the landmark UNLOAD study.
